TerrAscend expects Q3 2026 year-over-year revenue growth of 2% to 3% as it advances share consolidation vote and U.S. uplisting dialogue

Neutral

AI Analysis

Summary

TerrAscend expects Q3 2026 year-over-year revenue growth of 2% to 3% and is advancing a share consolidation vote while pursuing U.S. uplisting dialogue.

Financial Highlights

Guidance

Q3 2026 YoY revenue growth of 2% to 3%

Importance:3/10

Sentiment:

0.00

guidanceshare consolidationuplistingrevenue growth

Read the original article

Published by Seeking Alpha Healthcare on August 7, 2026 2:15 AM

Read Original